A61K 47/6885
The conjugate or the polymer being a starburst, a dendrimer, a cascade
Official title: {the conjugate or the polymer being a starburst, a dendrimer, a cascade}
A61K47/6885 (The conjugate or the polymer being a starburst, a dendrimer, a cascade) appears on 39 US grants and 74 published applications in this corpus.
Search patents in A61K- Granted patents
- 39
- Published applications
- 74
- Assignees
- 36
- Inventors
- 141
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 4 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 6 |
| 2012 | 1 | 1 |
| 2013 | 4 | 5 |
| 2014 | 3 | 2 |
| 2015 | 1 | 3 |
| 2016 | 2 | 6 |
| 2017 | 1 | 4 |
| 2018 | 1 | 5 |
| 2019 | 0 | 2 |
| 2020 | 1 | 1 |
| 2021 | 2 | 6 |
| 2022 | 1 | 10 |
| 2023 | 2 | 7 |
| 2024 | 4 | 6 |
| 2025 | 3 | 4 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Targeted dendrimer conjugates16 Jun 2026US 12,653,896 B2Starpharma Pty Limited
- Cyanine-based telodendrimers and uses for treating cancer20 Jan 2026US 12,527,880 B2The Regents of the University of California
- Complement factor D antagonist antibodies and conjugates thereof11 Nov 2025US 12,466,879 B2Kodiak Sciences Inc.
- Antibody-oligonucleotide conjugate28 Oct 2025US 12,453,782 B2Sapreme Technologies B.V.
- Nucleic acid carriers and therapeutic methods of use24 Jun 2025US 12,338,435 B2Code Biotherapeutics, Inc.
- Antibody-drug conjugate with improved therapeutic window1 Jan 2026US 2026/0000783 A1Sapreme Technologies B.V.
- Saponin Conjugates2 Oct 2025US 2025/0302983 A1Sapreme Technologies B.V.
- Peg based anti-cd47/anit-pd-l1 bispecific antibody-drug conjugate25 Sep 2025US 2025/0295804 A1Shenzhen Enduring Biotech, Ltd.
- Improved cell-targeting binding molecule19 Jun 2025US 2025/0195682 A1Sapreme Technologies B.V.
- Nucleic acid carriers and therapeutic methods of use13 Feb 2025US 2025/0049942 A1Code Biotherapeutics, Inc.
Most cited
By later US patents
- Dense star polymer conjugates191US 5,527,524 AThe Dow Chemical Company · 1996
- Starburst conjugates168US 5,338,532 AThe Dow Chemical Company · 1994
- Hyper comb-branched polymer conjugates81US 5,919,442 ADendritech, Inc. · 1999
- Starburst conjugates56US 6,177,414 B1The Dow Chemical Company · 2001
- Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases48US 8,349,332 B2IBC Pharmaceuticals, Inc. · 2013